Atara Biotherapeutics, Inc. - Common Stock (ATRA)

CUSIP: 046513107

Q3 2016 13F Holders as of 30 Sep 2016

Type / Class
Equity / Common Stock
Shares outstanding
8,165,808
Total 13F shares
22,400,142
Share change
+728,802
Total reported value
$479,016,785
Price per share
$21.39
Number of holders
72
Value change
+$15,346,848
Number of buys
39
Number of sells
25

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 046513107?
CUSIP 046513107 identifies ATRA - Atara Biotherapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of ATRA - Atara Biotherapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BAUPOST GROUP LLC/MA
13F
Company
66%
5,359,632
$120,645,000 30 Jun 2016
13F
FMR LLC
13F
Company
38%
3,125,407
$70,353,000 30 Jun 2016
13F
Redmile Group, LLC
13F
Company
30%
2,408,970
$54,226,000 30 Jun 2016
13F
ArrowMark Colorado Holdings LLC
13F
Company
15%
1,253,308
$28,212,000 30 Jun 2016
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
14%
1,152,663
$25,947,000 30 Jun 2016
13F
BRIDGER MANAGEMENT, LLC
13F
Company
12%
1,015,976
$22,870,000 30 Jun 2016
13F
EAGLE ASSET MANAGEMENT INC
13F
Company
12%
972,592
$21,893,000 30 Jun 2016
13F
BlackRock Fund Advisors
13F
Company
11%
913,922
$20,572,000 30 Jun 2016
13F
VANGUARD GROUP INC
13F
Company
8.3%
679,690
$15,300,000 30 Jun 2016
13F
Neuberger Berman Group LLC
13F
Company
7.7%
629,120
$14,161,000 30 Jun 2016
13F
BlackRock Institutional Trust Company, N.A.
13F
Company
6%
489,613
$11,021,000 30 Jun 2016
13F
RTW INVESTMENTS, LP
13F
Company
5.7%
465,874
$10,487,000 30 Jun 2016
13F
Slate Path Capital LP
13F
Company
5.1%
420,000
$9,454,000 30 Jun 2016
13F
12 West Capital Management LP
13F
Company
4.9%
398,700
$8,975,000 30 Jun 2016
13F
STATE STREET CORP
13F
Company
4.3%
355,001
$7,995,000 30 Jun 2016
13F
TIVERTON ASSET MANAGEMENT LLC
13F
Company
2.5%
203,863
$6,752,000 30 Jun 2016
13F
NORTHERN TRUST CORP
13F
Company
2.9%
240,735
$5,419,000 30 Jun 2016
13F
Cormorant Asset Management, LP
13F
Company
2.3%
186,460
$4,197,000 30 Jun 2016
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.7%
137,725
$3,100,000 30 Jun 2016
13F
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
13F
Company
1.5%
126,400
$2,845,000 30 Jun 2016
13F
Invesco Ltd.
13F
Company
1.3%
110,197
$2,480,000 30 Jun 2016
13F
TEACHERS ADVISORS, LLC
13F
Company
1.3%
102,251
$2,302,000 30 Jun 2016
13F
Bank of New York Mellon Corp
13F
Company
1.2%
99,627
$2,243,000 30 Jun 2016
13F
BlackRock Investment Management, LLC
13F
Company
1.2%
94,203
$2,121,000 30 Jun 2016
13F
JPMORGAN CHASE & CO
13F
Company
1.1%
90,135
$2,029,000 30 Jun 2016
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.93%
75,926
$1,708,000 30 Jun 2016
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.88%
71,630
$1,612,000 30 Jun 2016
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.81%
66,295
$1,493,000 30 Jun 2016
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.6%
48,704
$1,096,000 30 Jun 2016
13F
NORGES BANK
13F
Company
0.49%
40,010
$901,000 30 Jun 2016
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.45%
36,842
$830,000 30 Jun 2016
13F
Vident Investment Advisory, LLC
13F
Company
0.4%
32,879
$740,000 30 Jun 2016
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.33%
26,753
$602,000 30 Jun 2016
13F
RHUMBLINE ADVISERS
13F
Company
0.33%
26,645
$600,000 30 Jun 2016
13F
Swiss National Bank
13F
Company
0.32%
26,100
$588,000 30 Jun 2016
13F
ProShare Advisors LLC
13F
Company
0.3%
24,236
$546,000 30 Jun 2016
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.28%
22,940
$516,000 30 Jun 2016
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.27%
22,100
$497,000 30 Jun 2016
13F
CREDIT SUISSE AG/
13F
Company
0.25%
20,566
$463,000 30 Jun 2016
13F
METROPOLITAN LIFE INSURANCE CO/NY
13F
Company
0.22%
17,716
$399,000 30 Jun 2016
13F
MANUFACTURERS LIFE INSURANCE COMPANY, THE
13F
Company
0.2%
16,420
$370,000 30 Jun 2016
13F
Deutsche Girozentrale DekaBank
13F
Individual
0.2%
16,200
$365,000 30 Jun 2016
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.2%
16,110
$363,000 30 Jun 2016
13F
PARAMETRIC PORTFOLIO ASSOCIATES LLC
13F
Company
0.19%
15,720
$354,000 30 Jun 2016
13F
Nationwide Fund Advisors
13F
Company
0.19%
15,110
$340,000 30 Jun 2016
13F
AMERICAN INTERNATIONAL GROUP, INC.
13F
Company
0.16%
13,371
$300,981 30 Jun 2016
13F
VIRTUS ADVISERS, LLC
13F
Company
0.15%
12,651
$285,000 30 Jun 2016
13F
HARBOURVEST PARTNERS LLC
13F
Company
0.13%
10,543
$237,000 30 Jun 2016
13F
BLACKROCK ADVISORS LLC
13F
Company
0.12%
10,186
$229,000 30 Jun 2016
13F
VOYA INVESTMENT MANAGEMENT LLC
13F
Company
0.12%
10,162
$229,000 30 Jun 2016
13F

Institutional Holders of Atara Biotherapeutics, Inc. - Common Stock (ATRA) as of Q3 2016

As of 30 Sep 2016, Atara Biotherapeutics, Inc. - Common Stock (ATRA) was held by 72 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 22,400,142 shares. The largest 10 holders included BAUPOST GROUP LLC/MA, FMR LLC, Redmile Group, LLC, Arrowpoint Asset Management, LLC, BRIDGER MANAGEMENT, LLC, EAGLE ASSET MANAGEMENT INC, BlackRock Fund Advisors, UBS ASSET MANAGEMENT AMERICAS INC, VANGUARD GROUP INC, and Neuberger Berman Group LLC. This page lists 72 institutional shareholders reporting positions in this security for the Q3 2016 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2016 vs Q2 2016 Across Filers

Q2 2016 holders
70
Q3 2016 holders
72
Holder diff
2
Investor Q2 2016 Shares Q3 2016 Shares Share Diff Share Chg % Q2 2016 Value $ Q3 2016 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.